Nyxoah SA Ordinary Shares (NYXH) Dividend History

Company News

• Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025

  Nyxoah SA invites its shareholders to attend the annual and extraordinary shareholders' meetings on June 11, 2025. The meetings will cover the company's financial results, director appointments, and amendments to the remuneration policy.

  GlobeNewswire Inc.
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OSI Systems, Inc. - OSIS

  Pomerantz LLP is investigating claims on behalf of investors of OSI Systems, Inc. (OSIS) following a short report by Culper Research that alleges the company's reported growth in Mexico revenues is 'largely an illusion' and accuses it of 'downplaying' U.S. Department of Justice investigations.

  GlobeNewswire Inc.

  Featured Companies: HQY OSIS
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HealthEquity, Inc. - HQY

  HealthEquity, Inc. reported weaker-than-expected Q4 earnings and provided weak guidance for FY2026, citing increased cyber threats and fraud attacks, causing its stock price to drop significantly.

  GlobeNewswire Inc.

  Featured Companies: HQY OSIS
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  Nyxoah S.A. (NASDAQ: NYXH) received an Approvable Letter from the FDA for its Genio system, but analysts expect a delay in the commercial launch, causing the stock price to drop 21.36%.

  GlobeNewswire Inc.
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  Nyxoah S.A. (NASDAQ: NYXH) received an Approvable Letter from the FDA for its Genio system, but analysts expect a delay in the commercial launch pending further review. This news caused Nyxoah's stock price to fall by 21.36%.

  GlobeNewswire Inc.